ARCHIVES

Reed To Leave NCI Next Year; Allegra Moves To Extramural Side; Ozer Heads Okla. Center.

This article is from The Cancer Letter archive.

Vol. 26 No. 29 | July 21, 2000

Download PDF Visit The Full Archive

Related Articles

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

NCI-Approved CTEP Trials For the Month of September

September 28, 2012

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

DCT Board Approves Concept To Recomplete Data Management Contract

June 29, 1984

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

June 15, 2007

National Cancer Act: Early Promises Were Overstated

May 15, 1998